Acromegaly Community Educates and Improves Lives with Jill Sisco Patient Advocate TRANSCRIPT
Download PDFOct 14, 2020
Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from...
Oct 14, 2020
Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from...
Sep 17, 2020
Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies. Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly...
Sep 17, 2020
Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies. Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly...
Addressing Genetic Mutation that Leads to Rare Disease of the Immune System with Paula Ragan X4 Pharmaceuticals TRANSCRIPT
Download PDFAug 25, 2020
Paula Ragan, CEO and President, X4 Pharmamceuticals is developing innovative approaches to treat patients suffering from rare diseases with an initial focus on WHIM syndrome, a rare disease of the immune system that has a basis in a genetic mutation. X4 is also focused on a rare form of lymphoma called Waldenstrom...